- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03137680
Pre-Operative Forearm Exercise On Arteriovenous Fistula Mauration
Effect Of Pre-Operative Forearm Exercise On Arteriovenous Fistula Mauration and Blood Flow
To investigate the effect of pre-operative exercise on
- Hemodynamics in the fistula artery and vein, pre and post AV fistula formation
- Suitability of cannulation of AV fistula at 8weeks
Study Overview
Detailed Description
Aim: To investigate the effect of pre-operative exercise on hemodynamics in the fistula artery and vein, pre and post AV fistula formation as well as the suitability of cannulation of AV fistula at 8weeks post sugery
Methodology: This is a randomised control study with 20 patients each in the exercise arm and the control arm. The subjects will be randomised 1:1 into one of the two groups. Chronic Kidney failure patients with eGFR less than 20mls/min and have chosen Haemodialysis as their modality of renal replacement therapy will be included the study. All the subjects will have an ultrasound doppler vein mapping done prior to entering the study.
The exercise protocol for the intervention group will be to squeeze a soft ball 10 times for set and perform 3 sets of 10 squeezes each at an 1 minute interval. Three sets of exercises to be performed twice in the morning and twice in the evening, for a total of six weeks.
All patients will have a follow up ultrasound doppler of the AV fistula at 8 weeks and 16 weeks post-surgery, looking at the AV fistula vein diameter, arterial diameter and blood flow rate. All the subjects will also be seen by a single vascular surgeon following the scan, to assess the suitability for AVF cannulation.
Significance of the proposed study and benefits: A well functioning arterio-venous fistula is the gold standard vascular access for Hemodialysis patients due to its low rates of complications. The primary failure rate of the AVFs remain high at around 20 -25%, contributed by several factors including the diameter of the vessels. If pre-operative exercise improves the hemodynamics of the AV fistula and aids the maturation rate in our study, it can be incorporated into clinical guidelines to reduce the primary failure rate of AV fistulas.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Chronic Kidney failure patients with eGFR less than 20mls/min
- Chosen Hemodailysis as their modality of renal replacement therapy
Exclusion Criteria:
- Potential fistula vein diameter less than 3mm (with application of tornique) on initial vein mapping
- Known left ventricular ejection fraction of less than 20% on Echocardiogram
- Previous stroke effecting the AV fistula arm
- Calcified brachial or radial arteries and/or duplex evidence of stenosis of >50%
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control Arm
No specific exercise regime for the control group.
Usual hospital SOP will be adhered to
|
|
|
Experimental: Exercise Arm
The exercise protocol for the intervention group will be to squeeze a soft ball 10 times for set and perform 3 sets of 10 squeezes each at an 1 minute interval.
Three sets of exercises to be performed twice in the morning and twice in the evening, for a total of 6 weeks.
This will be performed at least 6 weeks prior to the creation of the AV fistula
|
Exercise protocol for the intervention group will be to squeeze a soft ball 10 times for set and perform 3 sets of 10 squeezes each at an 1 minute interval.
Three sets of exercises to be performed twice in the morning and twice in the evening, for a total of six weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hemodynamics in the fistula artery and vein, pre and post AV fistula formation
Time Frame: 22 weeks
|
AV fistula vein diameter, arterial diameter and blood flow rate will be assessed and compared
|
22 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Suitability of cannulation of AV fistula
Time Frame: 8 Weeks
|
Assessment of suitability of AV fistula cannulation by blinded vascular surgeon 8 week post creation
|
8 Weeks
|
|
Secondary fistula failure
Time Frame: 1 year
|
Fistula outcomes will be assessed to review the need for angiographic procedures for AVF maturation and also look at secondary fistula failure
|
1 year
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016/2573
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Arteriovenous Fistula
-
Medtronic EndovascularCompletedFistula | Arteriovenous Fistula | Arteriovenous Fistula Stenosis | Arteriovenous Fistula OcclusionNew Zealand, United States, Japan
-
Jiangsu Topcel-KH Pharmaceutical Co., Ltd.Not yet recruiting
-
Cardionovum GmbHNot yet recruitingArterio-venous Fistula | Stenosis of Arteriovenous Dialysis FistulaItaly
-
Hospital General Universitario Gregorio MarañonSpanish Society of NephrologyCompletedArteriovenous Fistula Stenosis | Arteriovenous Fistula ThrombosisSpain
-
Ai PengRecruitingArteriovenous Fistula Flow Monitoring | Early Detection of Complications of Arteriovenous Fistula | VoiceprintChina
-
Assiut UniversityNot yet recruitingArteriovenous Fistula Patency
-
Thomas Jefferson UniversityRecruitingSpinal Dural Arteriovenous FistulaUnited States
-
Combined military hospital lahoreRecruitingArteriovenous Fistula | Arteriovenous Fistula Occlusion | Endstage Renal Disease | Direct Oral Anticoagulants (DOACs)Pakistan
-
Suzhou Municipal Hospital of Anhui ProvinceRecruitingVascular Access | Arteriovenous Fistula | Vascular Access Complication | Arteriovenous Fistula Cannulation | Hemodialysis AccessChina
-
DK Medical Technology (Suzhou) Co., Ltd.RecruitingArteriovenous Fistula StenosisChina
Clinical Trials on Hand Exercise
-
The Arthritis Research Institute of AmericaCompletedOsteoarthritisUnited States
-
University of ManitobaCanadian Arthritis NetworkCompletedRheumatoid Arthritis | Osteoarthritis of HandsCanada
-
National and Kapodistrian University of AthensCompletedArthralgia | Systemic Lupus ErythematosusGreece
-
Istanbul University - CerrahpasaNot yet recruiting
-
Diakonhjemmet HospitalNorwegian Fund for Postgraduate Training in PhysiotherapyCompleted
-
Mansoura UniversityCompletedEnd-Stage Renal Disease | Arteriovenous Fistula | Chronic Kidney FailureEgypt
-
Sahachat AueyingsakUnknownCardiovascular Responses in Elderly With Isolated Systolic HypertensionThailand
-
Amasya UniversityCompleted
-
University of ManitobaUnknownStroke | HemiplegiaCanada
-
University of BaghdadActive, not recruitingFatigue | Anxiety | Hemodynamic ParametersIraq